Drawing for YUNGSHIN

USPTO serial 77395489

YUNGSHIN

Reviewed by CopyMark Law Group

Reg. 3914672Status 800Registered
Filing date
Status date
Registration date
Feb 1, 2011
Examiner
HAN, DAWN L
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with YUNGSHIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe McKinney Muncy

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, PC125 S. Royal StreetAlexandria, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Gastro-intestinal treatment preparations; cough drops; calcium supplement; analgesic preparations; oral analgesics; anti-inflammatories; anesthetics for surgical and non-surgical uses; sedatives; respiratory stimulants; pharmaceutical preparations to enhance digestion; antacids; nausea treatment preparation; diarrhea medications; laxatives; diuretic preparations; antibiotics; hemostatics; appetite suppressants for medical use; diet pills; medicated hair restoration lotions; hair growth stimulants; medicated scalp treatment cream; smoking cessation preparations; eczema treatment preparations; hemorrhoid treatment preparations; psoriasis treatment preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of arthritis; cough treatment preparations; highly caffeinated energy pills; breath-freshening chewing gum for medicinal purposes; blood plasma; antianginal preparation; acne treatment preparations; antipyretic analgesic; muscle relaxants; pharmaceutical anti-allergic preparations and substances; antidepressants; pharmaceutical preparations for the treatment of epilepsy, pharmaceutical preparations for the treatment of stomach ulcers, pharmaceutical preparations for the treatment of tuberculosis, pharmaceutical preparations for the treatment of Parkinson's disease, pharmaceutical preparations for the treatment of rheumatism, pharmaceutical preparations for the treatment of thrombosis, pharmaceutical preparations for the treatment of enuresis, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of dermatosis; steroid ointments; human hormone for human use; pharmaceutical preparations for the prevention and treatment of disorders of the immune system; antihistamines; bronchodilators; pharmaceutical preparations for skin care; syringes sold filled with hyaluronic acid for use in arthroscopic surgeries; pharmaceutical preparations for the treatment of eye diseases and conditions; anti-cancer preparations; pharmaceutical preparations for treating diabetes; cholesterol reducers; hypnotics; preparations for treating colds; antiarrhythmics; oxytocics; expectorants; uterine contraction pharmaceutical preparations; contraceptives; athletes foot preparations; patches containing mosquito-repellent incenses for human use; vitamins; Chinese medicines, namely, herb teas for medicinal purposes, pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceuticals, namely, inducers of erections; hepatotonic agents for hepatological diseases; pharmaceutical preparations for the treatment of liver diseases; vaccines for human purposes; antivirals; ointments for pharmaceutical purposes, namely, non-steroid anti-inflammatory ointments; ocular pharmaceuticals, namely, eye-wash; patches containing anti-inflammatories; pharmaceutical preparations for hemopoiesis; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; pharmaceutical preparations for burn treatment; gelatin capsules sold empty for pharmaceuticals; suppositories; insect-repellents; pregnancy test kits for home use; diagnostic test kits consisting of diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; ovulation test kits; mineral nutritional supplements; dietary supplements in capsules containing garlic extract; medicinal ganoderma lucidum extracts for medical purposes; food supplements, namely, anti-oxidants; dietary supplements containing shark cartilage; vitamin and mineral supplements; dietary supplements in capsule forms containing shark liver oils; dietary supplements in capsule forms containing chitin extract; bread that is gluten-free to accommodate special medical and health conditions; dietary and nutritionally fortified food products adapted for medical use; dietary fiber powder as an additive for food products for restricted diet; dandruff shampooACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2021NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jan 30, 2021RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 30, 202189AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 30, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 6, 2020E89RTEAS SECTION 8 & 9 RECEIVED—
Feb 1, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 6, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 6, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 6, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 26, 2016E815TEAS SECTION 8 & 15 RECEIVED—
Feb 1, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 28, 2010SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 27, 2010REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Dec 21, 2010CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 13, 2010SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 10, 2010IUAFUSE AMENDMENT FILED—
Dec 10, 2010EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 13, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 12, 2010EX2GSOU EXTENSION 2 GRANTED—
Jul 12, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 14, 2010EXT2SOU EXTENSION 2 FILED—
Jun 14, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2009EX1GSOU EXTENSION 1 GRANTED—
Dec 7, 2009EXT1SOU EXTENSION 1 FILED—
Dec 7, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2009NPUBNOTICE OF PUBLICATION—
Feb 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 14, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 2, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jan 2, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 2, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 2, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 12, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2008ALIEASSIGNED TO LIE—
Dec 1, 2008MAILPAPER RECEIVED—
May 30, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2008DOCKASSIGNED TO EXAMINER—
Feb 20, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Feb 19, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance